A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults

Clinical trial NCT04238975 · UNKNOWN

Trial details

NCT number: NCT04238975
Sponsor: Green Cross Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Tetanus Diphtheria Whooping Cough

Start date: 2019-10-14
Primary completion: 2021-02-01
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.